Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Ayahuasca

Ritualistic ayahuasca users tend to have positive health and psychosocial well-being

by Eric W. Dolan
March 2, 2019
in Ayahuasca, Psychopharmacology
(Photo credit: BurningMax)

(Photo credit: BurningMax)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

New research provides evidence that the ritualistic use of the psychedelic drug ayahuasca is not a significant public health concern — and could in fact have potential benefits. The study has been published in the Journal of Psychoactive Drugs.

“Ayahuasca is a decoction originally from the Amazon rainforest that has been spread throughout the world. At ICEERS, we are interested in researching the eventual risks and benefits of its use,” said study author Jose Carlos Bouso, the scientific director of the International Center for Ethnobotanical Education, Research, and Services in Spain.

“We studied in the past its neuropsychiatric effects on long-term ayahuasca users and did not find any disturbances. Now we are interested in studying the effects of ayahuasca from a public health perspective.”

The researchers surveyed 380 ritualistic ayahuasca users in Spain regarding their self-perceived health, body mass index, presence of chronic disease, sleep quality, and several other factors. Most of the participants had taken ayahuasca between one and 10 times in their lifetime. But a substantial percentage of participants (29.7%) reported taking ayahuasca more than 100 times.

The majority of the sample (96.6%) described their health as “good,” “very good,” or “excellent.” In addition, 43.7% reported being “quite happy,” 39.2% reported being “very happy,” and 7.5% reported being “immensely happy.”

Only 7.4% of participants had high cholesterol or blood pressure level, and 47% had visited a doctor between one and three times in the previous six months. Only 19% had visited a psychologist or psychiatrist in the previous six months.

The prevalence of chronic diseases was also lower among ritualistic ayahuasca users compared to the general Spanish population, while the prevalence of mental disturbance was similar between ayahuasca users and the general population.

“The key finding can be summarized using the following sentence of the Abstract section: ‘a respectful and controlled use of ayahuasca taken in community settings can be incorporated into modern society with benefits to public health.’ With the health indicators used, we noted that regular ayahuasca users have good general health, display healthy lifestyles and coping strategies, or show appropriate levels of social support and participation in cultural activities,” Bouso told PsyPost.

“This could serve as an example of how a traditional practice, even with its exoticism and cultural differences, can be effectively integrated in our society if it is used in controlled and respectful contexts.”

The study — like all research — includes some limitations. The use of a cross-sectional survey, for example, makes it difficult to assess the direction of cause and effect. It is possible that people with healthier lifestyles are drawn to ayahuasca, rather than ayahuasca use contributing to healthier lifestyles.

“The main limitation of this study is that the sample was self-selected. It is possible that only those who obtain some benefit from the regular use of ayahuasca are able to maintain this practice, so we may be underestimating potential risks and overestimating potential benefits. Further studies with larger samples are warranted,” Bouso said.

“This article will be part of a special 50th anniversary issue of the Journal of Psychoactive Drugs. MAPS (Multidisciplinary Association for Psychedelic Studies), the organization that is coordinating the issue, stated: ‘This carefully conducted study adds to the growing body of evidence that used carefully in specific settings, ayahuasca and other psychedelics may have real benefits for mental health and well-being. MAPS is delighted to be able to include these encouraging results in the Journal of Psychoactive Drugs’ historic 50th anniversary theme issue highlighting the leading edge of psychedelic research.’ The complete special issue will be available in print by June 2019.”

“ICEERS is also organizing the World Ayahuasca Conference, the biggest gathering in the world about ayahuasca. We invite readers to see the web site of the conference: http://www.ayaconference.com.”

The study, “Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users“, was authored by Genís Ona, Maja Kohek, Tomàs Massaguer, Alfred Gomariz, Daniel F. Jiménez, Rafael G. Dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar- Córcoles, and José Carlos Bouso.

RELATED

Stimulant medications normalize brain structure in children with ADHD, study suggests
Psychopharmacology

Study suggests smart drugs are used for optimization, not self-medication

November 12, 2025
From tango to StarCraft: Creative activities linked to slower brain aging, according to new neuroscience research
Addiction

Cannabis use associated with a reduction in alcohol intake

November 11, 2025
In neuroscience breakthrough, scientists identify key component of how exercise triggers neurogenesis
Cannabis

New study finds CBD worsens cannabis effects in schizophrenia

November 1, 2025
Familial link between ADHD and crime risk is partly genetic, study suggests
Caffeine

Scientists question caffeine’s power to shield the brain from junk food

October 31, 2025
The neuroscience of placebo analgesia: Brain pathway explains how expectations reduce pain
Cannabis

Omega-3 diet offsets some prenatal cannabis effects in male but not female offspring

October 30, 2025
Ketamine shows promise for severe obsessive-compulsive disorder in new study
Depression

“Major problem”: Ketamine fails to outperform placebo for treating severe depression in new clinical trial

October 28, 2025
Psychedelic mushrooms and quiet quitting: Psilocybin use tied to working fewer overtime hours
Depression

Psilocybin therapy linked to lasting depression remission five years later

October 27, 2025
Cannabis affects cognitive and psychomotor performance differently based on usage patterns
Cannabis

New research show how tobacco may worsen brain-related outcomes in cannabis users

October 24, 2025

PsyPost Merch

STAY CONNECTED

LATEST

Trauma history shapes how the brain adaptively responds to new stress

New study shows that not all forms of social rank are equally attractive

Grok’s views mirror other top AI models despite “anti-woke” branding

People who signal victimhood are seen as having more manipulative traits, according to new psychology research

New research reveals how estrogen amplifies the brain’s dopamine signals

Boosting NAD+ reverses Alzheimer’s-like deficits in animal models

New study explores how ADHD symptoms relate to menopause in midlife women

ChatGPT’s social trait judgments align with human impressions, study finds

RSS Psychology of Selling

  • How personal happiness shapes workplace flourishing among retail salespeople
  • Are sales won by skill or flexibility? A look inside investment banking sales strategies
  • Toxic leadership: How narcissistic bosses shape nurses’ workplaces
  • How supervisors influence front-line salespeople
  • Age shapes how brains respond to guilt-based deceptive advertising
         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy